Skip to content.

Metabolic Syndrome Institute

You are here: Home » News » Abdominal obesity underlies a high risk of all-cause and CV mortality in patients with end-stage renal failure


Abdominal obesity underlies a high risk of all-cause and CV mortality in patients with end-stage renal failure

Document Actions
  • Print this page
2009-may-28

The aim of this prospective cohort study was to investigate the predictive value of anthropometric measurements of abdominal obesity for all-cause and cardiovascular (CV) death in 537 patients with end-stage renal disease (ESRD). BMI-adjusted Cox models revealed that waist circumference was a direct predictor of all-cause and CV mortality, whereas BMI showed an inverse relationship with these outcomes. The incidence rates of overall and CV death were maximal in patients with relatively lower BMI scores and higher waist circumferences, and minimal in those with higher BMI scores and lower waist circumferences, suggestive of diverging fat as well as lean body mass. After adjusting for CV comorbidities and traditional and emerging risk factors, the predictive power of waist circumference for all-cause and CV mortality remained significant. Waist-to-hip ratio was also found to be significantly related to all-cause and CV mortality. Thus, abdominal obesity underlies a high risk of all-cause and CV mortality in ESRD patients.

Abstract

Keywords:
Abdominal obesity – BMI – Cardiovascular risk – Kidney disease – Waist circumference

Ongoing Trials
Metabolic Syndrome Institute Landmark Studies
Guidelines
Metabolic Syndrome Institute Guidelines
Cardiovascular risks calculators
Metabolic Syndrome Institute Cardiovascular risks calculators
How to measure your waistline ?
Metabolic Syndrome Institute Measure your waistline
MSI Meeting
Newsletter

What's new ?
MSI special session at WCC 2008
Web Conference
Metabolic Syndrome Institute Web Conferences
 

This site conforms to the following standards: